Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 2MG TABLET Actual shortage 2024-04-26 2024-04-26 226330
APO-METHYLPHENIDATE 10MG TABLET Actual shortage 2024-04-26 2024-05-03 226327
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226324
APO-CITALOPRAM 40MG TABLET Actual shortage 2024-04-26 2024-04-26 226321
APO-DUTASTERIDE 0.5MG CAPSULE Actual shortage 2024-04-26 2024-04-26 226318
APO-LEFLUNOMIDE 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226315
APO-CITALOPRAM 20MG TABLET Actual shortage 2024-04-26 2024-04-26 226312
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Actual shortage 2024-04-26 2024-04-26 226309
APO-LITHIUM CARBONATE 150MG CAPSULE Actual shortage 2024-04-19 2024-05-03 225802
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-19 2024-04-19 225799
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Actual shortage 2024-04-19 2024-05-03 225796
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-TADALAFIL 10MG TABLET Actual shortage 2024-04-19 2024-04-26 225790
APO-TADALAFIL PAH 20MG TABLET Resolved 2024-04-19 2024-05-03 225785
APO-WARFARIN 1MG TABLET Actual shortage 2024-04-19 2024-04-26 225782
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225779
APO-DASATINIB 70MG TABLET Actual shortage 2024-04-19 2024-05-03 225776
APO-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-19 2024-05-03 225773
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225770
APO-TRIMEBUTINE 100MG TABLET Actual shortage 2024-04-19 2024-04-19 225767

Showing 21 to 40 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
IBUPROFEN CAPLETS 400MG TABLET Discontinued 2019-01-07 2019-07-13 71451
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-07-22 71439
IBUPROFEN 200MG TABLET Discontinued 2019-01-07 2019-01-07 71436
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348

Showing 41 to 60 of 356